Safety of CAR-T Cell Therapy in Patients With Renal Failure/Acute Kidney Injury: Focused Review

Chimeric antigen receptor (CAR) T-cell therapy is novel immunotherapy targeting specifically cancerous cells, and has been shown to induce durable remissions in some refractory hematological malignancies. However, CAR T-cell therapy has adverse effects, such as cytokine release syndrome (CRS), immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Khan, Israr, Khan, Nida, Wolfson, Natalie, Djebabria, Kawthar, Rehman, Mohammad Ebad Ur, Anwer, Faiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241763/
https://www.ncbi.nlm.nih.gov/pubmed/37010812
http://dx.doi.org/10.1007/s44228-023-00037-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10241763/
https://www.ncbi.nlm.nih.gov/pubmed/37010812
http://dx.doi.org/10.1007/s44228-023-00037-7

Ejemplares similares